Litcius/Paper detail

Besides the front-line maintenance therapy, is any positive impact of poly (ADP-ribose) polymerase (PARP) inhibitors on recurrent high-grade ovarian cancer?

Yiu-Tai Li, Peng‐Hui Wang

2024Taiwanese Journal of Obstetrics and Gynecology13 citationsDOIOpen Access PDF

Topics & Concepts

Poly ADP ribose polymeraseFront lineOvarian cancerPolymerasePARP inhibitorCancer researchMaintenance therapyMedicineOncologyCancerInternal medicineBiologyEnzymeBiochemistryChemotherapyPolitical scienceLawOvarian cancer diagnosis and treatmentPARP inhibition in cancer therapyToxin Mechanisms and Immunotoxins
Besides the front-line maintenance therapy, is any positive impact of poly (ADP-ribose) polymerase (PARP) inhibitors on recurrent high-grade ovarian cancer? | Litcius